BTK inhibitors

An envelope with rejected mark Vector illustration
Biotech

FDA shares CRL for Sanofi MS drug mere weeks after rebuff

Less than two weeks after rejecting Sanofi’s investigational MS drug, the FDA has shared the CRL, citing both efficacy and safety concerns.
Gabrielle Masson Jan 6, 2026 4:30am
Job cuts employee layoffs firings or downsizing Scissors dividing individuals positioned on colorful blocks

Nurix trims staff as trial for lead BTK degrader kicks off

Nov 21, 2025 5:05am
Image comparing healthy and degraded myelin sheath

Roche reports phase 3 multiple sclerosis wins for BTK inhibitor

Nov 10, 2025 6:26am
Sanofi

Sanofi's troubled MS hopeful tolebrutinib hit by FDA delay

Sep 22, 2025 8:00am
Businessman climbing steps to pluck a star from the sky

Roche links BTK drug to low relapse rate across 96-week MS trial

May 30, 2025 5:19am
3D rendering of platelets

Sanofi BTK inhibitor for blood disease raises platelet levels

Nov 5, 2024 1:42pm